Ann: Investor Presentation, page-12

I emailed current ceo with questions and all I got back was 'will happily speak on the phone' which in my book means you can't trust my word and can't prove my word if it's not written down. No cred.

Whole board is responsible for the ridiculous spending that has happened over the past few years. They went too hard too early on pay packets when all focus should be on fda approval and increasing accuracy. Instead we've increased costs and accuracy on latest fda submission was one of the worst results we've seen. A larger team / advisory board and the product worsened..... Our only recovery is with Peta back onboard and removing current chairman imo